| Issuance |
Description |
Date Issued |
| BC 2004-19 |
Delisting of Rofecoxib from Bureau of Food and Drugs Registry of Drug Products |
Nov 26, 2004 |
| C 2024-002 |
Recall and Withdrawal of the Classification and Registration of Topical Corticosteroids as Over-the-Counter and Household Remedy Drug |
Mar 15, 2024 |
| C 2024-001 |
Recall and Withdrawal of the Classification and Registration of Domperidone as Over-the-Counter Drug |
Mar 15, 2024 |
| MC 2013-044 |
Warning on Toxic Enantiomer Levomethorphan Contaminated API Dextromethorphan Manufactured by Konduskar Laboratories Private Ltd., India |
Oct 23, 2013 |
| C 2020-010 |
Prohibition of Online Selling of Unregistered/Unnotified Medical Devices |
Mar 25, 2020 |
| C 2020-005-A |
Prohibition on the Online Selling of Essential Emergency Medical Supplies Beyond the Price Ceiling/Range |
Mar 25, 2020 |
| C 2020-005 |
Prohibition on the Online Selling of Essential Emergency Medical Supplies Beyond the Price Ceiling/Range |
Mar 12, 2020 |
| BC 2003-003-A |
Mandatory Dissemination of Information Regarding the Precaution/Warning of Drug Products Containing Phenylpropanolamine (PPA) |
Mar 17, 2003 |
| BC 2003-002 |
Classification of Paracetamol Syrup/Suspension 120 mg/5mL and 125 mg/5mL |
Feb 13, 2003 |
| BC 2001-018 |
Delisting of Levonorgestrel 750 mcg (Postinor) from Bureau of Food and Drugs Registry of Drug Products |
Dec 07, 2001 |
| BC 2000-004 |
Implementation of Administrative Order No. 13, s. 1999, "Use of Hydroquinone and/or Tretinoin (Retinoic Acid) |
Jun 08, 2000 |
| BC 199-16 |
Amending BFAD MC #22 Dated September 8, 1994 Regarding Inventory, Proper Disposal and/or Destruction of Used Vials or Bottles |
Jan 06, 1999 |
|
|
|